<p>China's CanSino Biologics Inc said on Monday it won approval for a clinical trial in the country to develop an inhaled version of its Covid-19 vaccine.</p>.<p>The National Medical Products Administration approved the trial of the vaccine, jointly developed by CanSino and the Beijing Institute of Biotechnology, the company said.</p>.<p>The vaccine was recently approved for emergency use in Hungary.</p>
<p>China's CanSino Biologics Inc said on Monday it won approval for a clinical trial in the country to develop an inhaled version of its Covid-19 vaccine.</p>.<p>The National Medical Products Administration approved the trial of the vaccine, jointly developed by CanSino and the Beijing Institute of Biotechnology, the company said.</p>.<p>The vaccine was recently approved for emergency use in Hungary.</p>